Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract CT082: Capmatinib in METex14-mutated (mut) advanced non-small cell lung cancer (NSCLC): Results from the phase II GEOMETRY mono-1 study, including efficacy in patients (pts) with brain metastases (BM)

Edward B. Garon, Rebecca S. Heist, Takashi Seto, Ji-Youn Han, Noemi Reguart, Harry J. Groen, Daniel SW Tan, Toyoaki Hida, Maja J. de Jonge, Sergey V. Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Sylvie Le Mouhaer, Anna Robeva, Maeve Waldron-Lynch, Monica Giovannini, Juergen Wolf

Cancer Res (2020) 80 (16_Supplement): CT082.

DOI: https://doi.org/10.1158/1538-7445.AM2020-CT082

Published: 15 August 2020

View article

Journal Articles

Abstract 5390: High serum interleukin 6 level associates with early death after initiation of treatment with PD-1 inhibitor in advanced NSCLC

Yuko Oya, Tatsuya Yoshida, Teppei Yamaguchi, Hiroaki Kuroda, Junichi Shimizu, Yoshitsugu Horio, Hirokazu Matsushita, Toyoaki Hida

Cancer Res (2020) 80 (16_Supplement): 5390.

DOI: https://doi.org/10.1158/1538-7445.AM2020-5390

Published: 15 August 2020

View article

Journal Articles

Abstract CT034: Osimertinib plus selumetinib for patients (pts) with EGFR-mutant (EGFRm) NSCLC following disease progression on an EGFR-TKI: Results from the Phase Ib TATTON study

Suresh S. Ramalingam, Hideo Saka, Myung-Ju Ahn, Helena Yu, Helena Yu, Leora Horn, Toyoaki Hida, Mireille Cantarini, Remy Verheijen, Jonathan Wessen, Geoffrey Oxnard, Yuichiro Ohe

Cancer Res (2019) 79 (13_Supplement): CT034.

DOI: https://doi.org/10.1158/1538-7445.AM2019-CT034

Published: 01 July 2019

View article

Journal Articles

Abstract 5003: Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma

Keiko Shinjo, Yasuyuki Okamoto, Ichiro Takeuchi, Makiko Fujii, Hirotaka Osada, Noriyasu Usami, Hidemi Ito, Toyoaki Hida, Yoshitaka Sekido, Yutaka Kondo

Cancer Res (2012) 72 (8_Supplement): 5003.

DOI: https://doi.org/10.1158/1538-7445.AM2012-5003

Published: 15 April 2012

View article

Journal Articles

Abstract 3082: TGF-β synergistically stimulates malignant mesothelioma growth with defects in the Hippo pathway by inducing CTGF expression

Makiko Fujii, Takeshi Toyoda, Hayao Nakanishi, Yasushi Yatabe, Ayuko Sato, Yasue Matsudaira, Hidemi Ito, Hideki Murakami, Yutaka Kondo, Eisaku Kondo, Tohru Tsujimura, Toyoaki Hida, Hirotaka Osada, Yoshitaka Sekido

Cancer Res (2012) 72 (8_Supplement): 3082.

DOI: https://doi.org/10.1158/1538-7445.AM2012-3082

Published: 15 April 2012

View article

Journal Articles

LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

Hideki Murakami, Tetsuya Mizuno, Tetsuo Taniguchi, Makiko Fujii, Futoshi Ishiguro, Takayuki Fukui, Shinya Akatsuka, Yoshitsugu Horio, Toyoaki Hida, Yutaka Kondo, Shinya Toyokuni, Hirotaka Osada, Yoshitaka Sekido

Cancer Res (2011) 71 (3): 873–883.

DOI: https://doi.org/10.1158/0008-5472.CAN-10-2164

Published: 01 February 2011

View article

Includes: Supplementary data

Journal Articles

Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma

Cancer Res (2009) 69 (23): 9073–9082.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-1595

Published: 30 November 2009

View article

Includes: Supplementary data

Journal Articles

Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent nonrandom chromosomal alteration regions including JUN amplification on 1p32

Tetsuo Taniguchi, Sivasundaram Karnan, Takayuki Fukui, Toshihiko Yokoyama, Hiroyuki Tagawa, Kohei Yokoi, Yuichi Ueda, Tetsuya Mitsudomi, Yoshitsugu Horio, Toyoaki Hida, Yasushi Yatabe, Masao Seto, Yoshitaka Sekido

Cancer Res (2007) 67 (9_Supplement): 4439.

Published: 01 May 2007

View article

Journal Articles

CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells.

Hidemasa Nagai, Nobuyoshi Sugito, Hideo Matsubara, Yoshio Tatematsu, Toyoaki Hida, Yoshitaka Sekido, Masato Nagino, Yuji Nimura, Takashi Takahashi, Hirotaka Osada

Cancer Res (2007) 67 (9_Supplement): 1354.

Published: 01 May 2007

View article

Journal Articles

Establishment and Characterization of a Human Lung Cancer Cell Line NCI-H460-LNM35 with Consistent Lymphogenous Metastasis via Both Subcutaneous and Orthotopic Propagation

Ken-ichi Kozaki, Osamu Miyaishi, Tetsuya Tsukamoto, Yoshio Tatematsu, Toyoaki Hida, Toshitada Takahashi, Takashi Takahashi

Cancer Res (2000) 60 (9): 2535–2540.

Published: 01 May 2000

View article

Journal Articles

Increased Expression of Cyclooxygenase 2 Occurs Frequently in Human Lung Cancers, Specifically in Adenocarcinomas

Toyoaki Hida, Yasushi Yatabe, Hiroyuki Achiwa, Hideki Muramatsu, Ken-ichi Kozaki, Shigeo Nakamura, Makoto Ogawa, Tetsuya Mitsudomi, Takahiko Sugiura, Takashi Takahashi

Cancer Res (1998) 58 (17): 3761–3764.

Published: 01 September 1998

View article

Journal Articles

Breast Cancer Growth Is Inhibited by Vasoactive Intestinal Peptide (VIP) Hybrid, a Synthetic VIP Receptor Antagonist

Hasan Zia, Toyoaki Hida, Sonia Jakowlew, Michael Birrer, Yehoshua Gozes, Jean C. Reubi, Mati Fridkin, Illana Gozes, Terry W. Moody

Cancer Res (1996) 56 (15): 3486–3489.

Published: 01 August 1996

View article

Journal Articles

Recombinant Human Stem Cell Factor Mediates Chemotaxis of Small-Cell Lung Cancer Cell Lines Aberrantly Expressing the c-kit Protooncogene

Yoshitaka Sekido, Takashi Takahashi, Ryuzo Ueda, Masahide Takahashi, Hiroko Suzuki, Keiko Nishida, Tetsuya Tsukamoto, Toyoaki Hida, Kaoru Shimokata, Krisztina M. Zsebo, Toshitada Takahashi

Cancer Res (1993) 53 (7): 1709–1714.

Published: 01 April 1993

View article

Journal Articles

Wild-type but not Mutant p53 Suppresses the Growth of Human Lung Cancer Cells Bearing Multiple Genetic Lesions

Takashi Takahashi, David Carbone, Toshitada Takahashi, Marion M. Nau, Toyoaki Hida, Ilona Linnoila, Ryuzo Ueda, John D. Minna

Cancer Res (1992) 52 (8): 2340–2343.

Published: 01 April 1992

View article

Journal Articles

Preferential Expression of c-kit Protooncogene Transcripts in Small Cell Lung Cancer

Yoshitaka Sekido, Yuichi Obata, Ryuzo Ueda, Toyoaki Hida, Motokazu Suyama, Kaoru Shimokata, Yutaka Ariyoshi, Toshitada Takahashi

Cancer Res (1991) 51 (9): 2416–2419.

Published: 01 May 1991

View article

Journal Articles

Chemosensitivity and Radiosensitivity of Small Cell Lung Cancer Cell Lines Studied by a Newly Developed 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT) Hybrid Assay

Toyoaki Hida, Ryuzo Ueda, Takashi Takahashi, Hiroyoshi Watanabe, Taketoshi Kato, Motokazu Suyama, Takahiko Sugiura, Yutaka Ariyoshi, Toshitada Takahashi

Cancer Res (1989) 49 (17): 4785–4790.

Published: 01 September 1989

View article

Journal Articles

Expression and Amplification of myc Gene Family in Small Cell Lung Cancer and Its Relation to Biological Characteristics

Takashi Takahashi, Yuichi Obata, Yoshitaka Sekido, Toyoaki Hida, Ryuzo Ueda, Hiroyoshi Watanabe, Yutaka Ariyoshi, Takahito Sugiura, Toshitada Takahashi

Cancer Res (1989) 49 (10): 2683–2688.

Published: 01 May 1989

View article

NARROW

Abstract CT082: Capmatinib in METex14-mutated (mut) advanced non-small cell lung cancer (NSCLC): Results from the phase II GEOMETRY mono-1 study, including efficacy in patients (pts) with brain metastases (BM)

Abstract 5390: High serum interleukin 6 level associates with early death after initiation of treatment with PD-1 inhibitor in advanced NSCLC

Abstract CT034: Osimertinib plus selumetinib for patients (pts) with EGFR-mutant (EGFRm) NSCLC following disease progression on an EGFR-TKI: Results from the Phase Ib TATTON study

Abstract 5003: Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma

Abstract 3082: TGF-β synergistically stimulates malignant mesothelioma growth with defects in the Hippo pathway by inducing CTGF expression

LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma

Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent nonrandom chromosomal alteration regions including JUN amplification on 1p32

CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells.

Establishment and Characterization of a Human Lung Cancer Cell Line NCI-H460-LNM35 with Consistent Lymphogenous Metastasis via Both Subcutaneous and Orthotopic Propagation

Increased Expression of Cyclooxygenase 2 Occurs Frequently in Human Lung Cancers, Specifically in Adenocarcinomas

Breast Cancer Growth Is Inhibited by Vasoactive Intestinal Peptide (VIP) Hybrid, a Synthetic VIP Receptor Antagonist

Recombinant Human Stem Cell Factor Mediates Chemotaxis of Small-Cell Lung Cancer Cell Lines Aberrantly Expressing the c-kit Protooncogene

Wild-type but not Mutant p53 Suppresses the Growth of Human Lung Cancer Cells Bearing Multiple Genetic Lesions

Preferential Expression of c-kit Protooncogene Transcripts in Small Cell Lung Cancer

Chemosensitivity and Radiosensitivity of Small Cell Lung Cancer Cell Lines Studied by a Newly Developed 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT) Hybrid Assay

Expression and Amplification of myc Gene Family in Small Cell Lung Cancer and Its Relation to Biological Characteristics

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only